CreativeOne Wealth LLC Boosts Holdings in Axon Enterprise, Inc $AXON

CreativeOne Wealth LLC increased its position in Axon Enterprise, Inc (NASDAQ:AXON) by 184.5% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 7,012 shares of the biotechnology company’s stock after purchasing an additional 4,547 shares during the quarter. CreativeOne Wealth LLC’s holdings in Axon Enterprise were worth $5,032,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also added to or reduced their stakes in the company. Newbridge Financial Services Group Inc. lifted its holdings in Axon Enterprise by 2.8% in the 2nd quarter. Newbridge Financial Services Group Inc. now owns 508 shares of the biotechnology company’s stock worth $421,000 after buying an additional 14 shares in the last quarter. Vicus Capital grew its stake in shares of Axon Enterprise by 3.7% during the third quarter. Vicus Capital now owns 396 shares of the biotechnology company’s stock valued at $284,000 after acquiring an additional 14 shares in the last quarter. Evergreen Capital Management LLC grew its stake in shares of Axon Enterprise by 3.8% during the second quarter. Evergreen Capital Management LLC now owns 413 shares of the biotechnology company’s stock valued at $342,000 after acquiring an additional 15 shares in the last quarter. STF Management LP increased its position in shares of Axon Enterprise by 1.4% during the second quarter. STF Management LP now owns 1,164 shares of the biotechnology company’s stock worth $964,000 after acquiring an additional 16 shares during the last quarter. Finally, Blue Trust Inc. increased its position in shares of Axon Enterprise by 2.5% during the third quarter. Blue Trust Inc. now owns 645 shares of the biotechnology company’s stock worth $463,000 after acquiring an additional 16 shares during the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.

Axon Enterprise Trading Up 0.6%

Shares of NASDAQ AXON opened at $574.01 on Monday. The company has a quick ratio of 2.29, a current ratio of 2.53 and a debt-to-equity ratio of 0.53. The stock’s 50 day moving average price is $536.08 and its two-hundred day moving average price is $616.86. Axon Enterprise, Inc has a 52-week low of $396.41 and a 52-week high of $885.91. The stock has a market capitalization of $46.15 billion, a P/E ratio of 377.64, a PEG ratio of 12.25 and a beta of 1.46.

Axon Enterprise (NASDAQ:AXON) last issued its earnings results on Tuesday, February 24th. The biotechnology company reported $2.15 EPS for the quarter, topping the consensus estimate of $1.60 by $0.55. Axon Enterprise had a return on equity of 2.82% and a net margin of 4.48%.The company had revenue of $796.72 million during the quarter, compared to analyst estimates of $755.29 million. During the same quarter last year, the firm earned $2.08 EPS. The business’s revenue was up 38.5% on a year-over-year basis. On average, analysts anticipate that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Axon Enterprise News Roundup

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Q4 revenue and bookings beat expectations — Axon reported quarterly revenue of ~$796.7M (up ~38.5% YoY) and said bookings were at record levels, driven by recurring software/services and AI products; investors are rewarding the growth narrative. Read More.
• Positive Sentiment: AI and acquisitions broaden the TAM — Axon is rolling out AI tools (Draft One) and expanding into emergency communications via buys like Carbyne and Prepared, pushing the company from hardware into a higher‑margin, recurring‑revenue public‑safety platform. Read More.
• Positive Sentiment: Hardware momentum in Connected Devices — demand for TASER 10, Axon Body 4 and counter‑drone solutions boosted device sales, helping current revenue strength and cross‑sell into Axon Cloud subscriptions. Read More.
• Neutral Sentiment: Street attention and bull narratives — multiple outlets and bullish newsletters have flagged Axon as a pick, increasing retail/institutional focus but also raising expectations. Read More.
• Negative Sentiment: Profitability collapsed despite revenue growth — quarterly net income plunged (reported near break‑even), compressing EPS and margins; that raises near‑term profitability and margin recovery questions. Read More.
• Negative Sentiment: Insider selling — Axon’s CAO sold 1,500 shares (~$860k), which may be viewed negatively by some investors even though the remaining insider stake remains material. Read More.
• Negative Sentiment: Analysts trimmed targets — some firms cut price targets (Morgan Stanley, Barclays) even as many maintain buy/overweight positions, signaling debate about valuation vs. execution. Read More.
• Negative Sentiment: High valuation and execution risk — AXON trades at a very high P/E, leaving the stock sensitive to execution on margin recovery, successful AI monetization and integration of acquisitions. Read More.

Analyst Ratings Changes

A number of research analysts recently commented on the company. Robert W. Baird set a $800.00 price target on Axon Enterprise in a report on Wednesday, February 25th. William Blair restated an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 3rd. Piper Sandler cut their target price on Axon Enterprise from $753.00 to $690.00 and set an “overweight” rating on the stock in a research report on Wednesday, February 25th. Needham & Company LLC decreased their price target on shares of Axon Enterprise from $870.00 to $600.00 and set a “buy” rating for the company in a research report on Friday, February 20th. Finally, Craig Hallum restated a “buy” rating and issued a $820.00 price target on shares of Axon Enterprise in a research note on Wednesday, February 25th. Sixteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, Axon Enterprise currently has an average rating of “Moderate Buy” and an average target price of $762.93.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, insider Isaiah Fields sold 2,000 shares of the stock in a transaction on Friday, February 27th. The shares were sold at an average price of $535.01, for a total transaction of $1,070,020.00. Following the sale, the insider directly owned 55,588 shares of the company’s stock, valued at approximately $29,740,135.88. This represents a 3.47% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Jennifer H. Mak sold 1,500 shares of the firm’s stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $573.45, for a total transaction of $860,175.00. Following the completion of the transaction, the chief accounting officer owned 12,240 shares in the company, valued at approximately $7,019,028. The trade was a 10.92% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 26,634 shares of company stock worth $14,963,095 in the last ninety days. 5.70% of the stock is currently owned by company insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.